-+ 0.00%
-+ 0.00%
-+ 0.00%

Legend Biotech Reports CARVYKTI Achieves 50.4-Month Median PFS in Multiple Myeloma Trial

路透·12/06/2025 19:00:28

登录查看新闻详情